WuXi PharmaTech, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today opened for trading on the New York Stock Exchange under the ticker symbol “WX” after its successful IPO in which it raised $185 million.E-House (China ) Holdings Ltd., a leading provider of real estate services in China , yesterday opened for trading on the New York Stock Exchange under the ticker symbol “EJ” after its successful IPO raised $201 million.
"With the additions of Wuxi PharmaTech and E-House to our growing family of world-class listed companies, the New York Stock Exchange is now privileged to list 40 companies from Greater China," said NYSE Euronext John A. Thain. "We welcome the opportunity to offer Wuxi PharmaTech and E-House access to the U.S. capital marketplace and the world's largest pool of investors, and are committed to growing our partnership with the people and business community of China . NYSE Euronext also looks forward to providing these outstanding companies and their shareholders with the superior service, market quality and brand visibility that come with listing on NYSE Euronext markets."
The combined global market capitalization of the 40 NYSE-listed companies from Greater China listed on the NYSE is $1 trillion (July 31, 2007 ). The NYSE roster of companies from Greater China includes 28 from Mainland China , 7 from Hong Kong and 5 from Taiwan .
To celebrate today’s special occasion, WuXi PharmaTech Chairman and CEO Ge Li, joined by company executives and NYSE Euronext CEO John A. Thain, rang the opening bell.
View listed companies from Mainland China.
View listed companies from Hong Kong.
View listed companies from Taiwan.
About WuXi PharmaTech (NYSE: WX)
Founded in 2000, Shanghai-based WuXi PharmaTech is the leading China-based pharmaceutical and biotechnology R&D outsourcing company. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical and biotechnology companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug discovery and development process. WuXi PharmaTech’s services are designed to assist its global partners in shortening the cycle and lowering the cost of drug discovery and development by providing cost-effective and efficient outsourcing solutions that save its customers both time and money. Its operations are grouped into two segments: laboratory services, consisting of discovery chemistry, service biology, analytical, pharmaceutical development and process development services, and manufacturing, focusing on manufacturing of advanced intermediates and active pharmaceutical ingredients for R&D use. In 2006, WuXi PharmaTech provided services to 70 pharmaceutical and biotechnology customers, including nine of the top 10 pharmaceutical companies in the world, as measured by 2006 total revenues.
About E-House (NYSE: EJ)
E-House (China ) Holdings Limited (“E-House”) is a leading real estate services company in China based on scope of services, brand recognition and geographical presence. Since its inception in 2000, E-House has experienced rapid growth and has become the largest real estate agency and consulting services company in China . E-House provides primary real estate agency services, secondary real estate brokerage services and real estate consulting and information services, and has received numerous awards and accolades for its innovation and quality, including “China ’s Best Company” from the National Association of Real Estate Brokerage and Appraisal Companies in 2006. E-House believes it has the largest and most comprehensive real estate database system in China , providing up-to-date and in-depth information covering residential and commercial real estate properties in all major regions in China .
About NYSE Euronext (NYSE: NYX)
NYSE Euronext, a holding company created by the combination of NYSE Group, Inc. and Euronext N.V., commenced trading on April 4, 2007 . NYSE Euronext (NYSE Euronext: NYX) operates the world’s largest and most liquid exchange group and offers the most diverse array of financial products and services. NYSE Euronext, which brings together six cash equities exchanges in five countries and six derivatives exchanges in six countries, is a world leader for listings, trading in cash equities, equity and interest rate derivatives, bonds and the distribution of market data. Representing a combined €21.7/$29.6 trillion total market capitalization of listed companies and average daily trading value of approximately €85/$115 billion (as of April 30, 2007), NYSE Euronext seeks to provide the highest standards of market quality and integrity, innovative products and services to investors, issuers, and all users of its markets.
No comments:
Post a Comment